Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,253
Total Claims
$812K
Drug Cost
715
Beneficiaries
$1,136
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+196%
Opioid rate vs peers
11.2% vs 3.8% avg
-3%
Cost per patient vs peers
$1,136 vs $1,174 avg
+117%
Brand preference vs peers
19.2% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
11.2%
Opioid Rate
1,037
Opioid Claims
$23K
Opioid Cost
11.9%
Long-Acting Rate
Brand vs Generic
Brand: 1,771 claims · $606K
Generic: 7,431 claims · $206K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 138 | $101K |
| Apixaban | 219 | $70K |
| Rivaroxaban | 117 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 143 | $35K |
| Deutetrabenazine | 16 | $30K |
| Cinacalcet Hcl | 12 | $25K |
| Insulin Glargine,hum.Rec.Anlog | 63 | $20K |
| Insulin Aspart | 52 | $20K |
| Insulin Lispro | 54 | $20K |
| Dapagliflozin Propanediol | 47 | $13K |
| Empagliflozin | 40 | $13K |
| Mirabegron | 36 | $12K |
| Sacubitril/Valsartan | 30 | $10K |
| Insulin Detemir | 23 | $9,908 |
| Fluticasone/Umeclidin/Vilanter | 14 | $9,625 |
Prescribing Profile
Patient Profile
76
Avg Age
63%
Female
2.86
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data